A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0. It has been cited 251 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Melanoma Research Alliance
Grant: Pilot Grant
Duke University School of Medicine
Grant: Duke University Health Scholar Award
NCI NIH HHS
Grant: P30 CA014236
NCI NIH HHS
Grant: P50 CA098131
NCI NIH HHS
Grant: K08 CA191063
National Institute of Health
Grant: K08 CA191063-04
NCI NIH HHS
Grant: R37 CA249085
AstraZeneca
Grant: Pre-Clinical Research Grant
NIGMS NIH HHS
Grant: T32 GM007171
National Institutes of Health
Grant: 5K08CA191063-03
Melanoma-mediated Dendritic Cell Tolerization and Immune Evasion
FWCI
9.74
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals